Hutchison China MediTech Limited (HCM) Insider Sells £268,500 in Stock
Hutchison China MediTech Limited (LON:HCM) insider Michael Howell sold 15,000 shares of the company’s stock in a transaction on Friday, October 7th. The stock was sold at an average price of GBX 1,790 ($22.15), for a total transaction of £268,500 ($332,301.98).
Hutchison China MediTech Limited (LON:HCM) opened at 1830.00 on Wednesday. The firm’s market capitalization is GBX 1.11 billion. Hutchison China MediTech Limited has a 12-month low of GBX 1,612.50 and a 12-month high of GBX 2,896.60. The firm has a 50 day moving average of GBX 1,820.62 and a 200 day moving average of GBX 1,846.45.
Several equities analysts have commented on the stock. Beaufort Securities reiterated a “buy” rating on shares of Hutchison China MediTech Limited in a report on Wednesday, August 3rd. Panmure Gordon reiterated an “under review” rating on shares of Hutchison China MediTech Limited in a report on Monday, June 20th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/hutchison-china-meditech-limited-hcm-insider-sells-268500-in-stock.html
About Hutchison China MediTech Limited
Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.
Receive News & Ratings for Hutchison China MediTech Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech Limited and related companies with MarketBeat.com's FREE daily email newsletter.